R. Gosens (Groningen, Netherlands), L. Stanciu (Cluj-Napoca, Romania)
Characterisation of a steroid-insensitive severe asthma model
P. Nath, A. Young, V. Russell (Harlow, United Kingdom)
|  |
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
K. I. Tanaka, T. Mizushima (Tokyo, Japan)
|  |
Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma
O. Danov, S. M. Jimenez Delgado, H. Drake, O. Pfennig, C. Förster, A. Braun, K. Sewald (Hannover, Germany)
| |
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
A. CorrêaFlorencio, F. M. Arantes-Costa, R. Santos de Almeida, S. S. S. Hamaguchi, S. D. Sasaki, M. A. Martins, I. F. L. C. Tibério, F. D. T. Q. S Lopes, E. A. Leick (São Paulo, Santo André, Brazil)
| |
Effects of cyclosporin H on airway inflammatory responses induced by mitochondrial damage-associated molecular patterns
M. Li, X. Zhang, L. Jia, H. Long, Y. Shen, C. Pang, F. Wen (Chengdu, China)
| |
Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Y. Vasquez, C. Page (London, United Kingdom)
| |
In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window
G. Villetti, P. T. Bolzoni, F. Bassani, M. Bergamaschi, P. L. Caruso, L. Battipaglia, A. Sala, F. Facchinetti, C. Carnini, M. Civelli (Parma, Milan, Italy)
| |
Acute markers of neutrophilic lung infiltration in the non-human primate LPS model
S. Jordan, E. Spridgen, V. Fisher, J. Hincks, T. Grasiewicz, K. Meecham (Cambridge, United Kingdom)
| |
Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR)
J. Fisher, S. Vincent, P. Wannas, J. Wess (Kingston, Canada; Bethesda, United States Of America)
| |
cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model
M. Terakawa, M. Goto, T. Tomoo, T. Katayama, Y. Hayashi, K. Nagahira (Kobe, Japan)
| |
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
F. Greiffo, A. Brito, E. Silveira, G. Moraes, F. Cipriani, V. Neves, C. Czeresnia, P. Perin, M. Nisenbaum, M. Maluf, F. Aimbire, J. P. Peron, R. Vieira, A. P. Oliveira (São Paulo, Brazil)
| |
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
J. P. Peron, G. Moraes, A. Brito, E. Silveira, B. Rodrigues Jr., R. Avelino, B. Franco, G. Rossi, M. Pellaty, M. Zats, L. Evangelista, S. Halpern, R. Vieira, A. P. Oliveira (São Paulo, Brazil)
| |
Importance of surface cooling during targeted lung denervation for COPD
M. Mayse, P. Johnson, J. Hummel (Minneapolis, Chapel Hill, United States Of America)
| |
A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4
J. Seibel, C. Pergola, O. Werz, K. Wosikowski, M. D. Lehner, J. Haunschild (Neumarkt, Jena, Germany)
| |
A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Y. Vasquez, A. Lightfoot, C. Page (London, United Kingdom)
| |
Lipid derivatives of dopamine and respiration
D. Zajac, A. Stasinska, M. Pokorski (Warsaw, Poland)
| |
Aminophylline increases ventilation and crural diaphragm contractility in awake canines
J. Jagers, B. Rothwell, P. Easton (Calgary, Canada)
| |
N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome
J. Kopincova, P. Mikolka, D. Mokra, A. Calkovska (Martin, Slovakia)
| |